#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat|salience|identity|centering
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent
#Summary1=(human1) This report on a followup and chemotherapy visit for 51-year-old white male patient with posttransplant lymphoproliferative disorder (diagonosed 2007) documents chronic renal insufficiency, squamous cell carcinoma of the skin, anemia and hypertension, as well as diffuse large B-cell lymphoma following transplantaiton and suggests followup in 3 weeks.
#Summary2=(claude-3-5-sonnet-20241022) A 51-year-old white male with posttransplant lymphoproliferative disorder, chronic renal insufficiency, skin cancer, anemia, and hypertension is completing his sixth cycle of chemotherapy after prior complications, with plans for PET scan and follow-up labs in 2-3 weeks.
#Summary3=(gpt4o) A 51-year-old male with posttransplant lymphoproliferative disorder, chronic renal insufficiency, skin squamous cell carcinoma, chemotherapy-related anemia, and hypertension is receiving his final chemotherapy cycle, feeling well despite previous complications such as sepsis, with a PET scan and follow-up visit planned within three weeks.
#Summary4=(Meta-Llama-3-8B-Instruct) A 51-year-old male with posttransplant lymphoproliferative disorder, chronic renal insufficiency, and squamous cell carcinoma undergoes chemotherapy and follows up with normal vital signs and laboratory results.
#Summary5=(Qwen2.5-3B-Instruct) A 51-year-old man with posttransplant lymphoproliferative disorder and chronic renal insufficiency is scheduled for his sixth and final chemotherapy cycle, presenting with anemia, an open wound from squamous cell carcinoma, and controlled hypertension.


#Text=Description :
1-1	0-11	Description	_	_	_	_	cf1[1]	_	_
1-2	12-13	:	_	_	_	_	_	_	_

#Text=Posttransplant lymphoproliferative disorder , chronic renal insufficiency , squamous cell carcinoma of the skin , anemia secondary to chronic renal insufficiency and chemotherapy , and hypertension .
2-1	14-28	Posttransplant	_	_	_	Post%2Dtransplant_lymphoproliferative_disorder[3]	cf4[3]	_	_
2-2	29-48	lymphoproliferative	_	_	_	Post%2Dtransplant_lymphoproliferative_disorder[3]	cf4[3]	_	_
2-3	49-57	disorder	_	_	_	Post%2Dtransplant_lymphoproliferative_disorder[3]	cf4[3]	_	_
2-4	58-59	,	_	_	_	_	_	_	_
2-5	60-67	chronic	_	_	_	_	cf1[4]	_	_
2-6	68-73	renal	_	_	_	_	cf1[4]|cf2[5]	_	_
2-7	74-87	insufficiency	_	_	_	_	cf1[4]	_	_
2-8	88-89	,	_	_	_	_	_	_	_
2-9	90-98	squamous	_	_	_	_	cf5[7]|cf9[8]	_	_
2-10	99-103	cell	_	_	_	_	cf5[7]|cf9[8]	_	_
2-11	104-113	carcinoma	_	_	_	_	cf5[7]	_	_
2-12	114-116	of	_	_	_	_	cf5[7]	_	_
2-13	117-120	the	object[9]	new[9]	snnnn[9]	_	cf5[7]|cf3[9]	coref	9-6[34_9]
2-14	121-125	skin	object[9]	new[9]	snnnn[9]	_	cf5[7]|cf3[9]	_	_
2-15	126-127	,	_	_	_	_	_	_	_
2-16	128-134	anemia	_	_	_	_	cf6[10]	_	_
2-17	135-144	secondary	_	_	_	_	cf6[10]	_	_
2-18	145-147	to	_	_	_	_	cf6[10]	_	_
2-19	148-155	chronic	_	_	_	_	cf6[10]|cf1[11]	_	_
2-20	156-161	renal	_	_	_	_	cf6[10]|cf1[11]|cf2[12]	_	_
2-21	162-175	insufficiency	_	_	_	_	cf6[10]|cf1[11]	_	_
2-22	176-179	and	_	_	_	_	cf6[10]	_	_
2-23	180-192	chemotherapy	_	_	_	_	cf6[10]|cf7[13]	_	_
2-24	193-194	,	_	_	_	_	_	_	_
2-25	195-198	and	_	_	_	_	_	_	_
2-26	199-211	hypertension	_	_	_	_	cf8[14]	_	_
2-27	212-213	.	_	_	_	_	_	_	_

#Text=The patient is here for followup visit and chemotherapy .
3-1	214-217	The	person[18]	new[18]	sssss[18]	_	cf2[18]	coref	5-1[23_18]
3-2	218-225	patient	person[18]	new[18]	sssss[18]	_	cf2[18]	_	_
3-3	226-228	is	_	_	_	_	_	_	_
3-4	229-233	here	_	_	_	_	_	_	_
3-5	234-237	for	_	_	_	_	_	_	_
3-6	238-246	followup	_	_	_	_	cf3[19]	_	_
3-7	247-252	visit	_	_	_	_	cf3[19]	_	_
3-8	253-256	and	_	_	_	_	_	_	_
3-9	257-269	chemotherapy	_	_	_	_	cf1*[20]	_	_
3-10	270-271	.	_	_	_	_	_	_	_

#Text=CHIEF COMPLAINT :
4-1	272-277	CHIEF	_	_	_	_	cf1[22]	_	_
4-2	278-287	COMPLAINT	_	_	_	_	cf1[22]	_	_
4-3	288-289	:	_	_	_	_	_	_	_

#Text=The patient is here for followup visit and chemotherapy .
5-1	290-293	The	person[23]	giv:inact[23]	sssss[23]	_	cf1[23]	coref	13-1[45_23]
5-2	294-301	patient	person[23]	giv:inact[23]	sssss[23]	_	cf1[23]	_	_
5-3	302-304	is	_	_	_	_	_	_	_
5-4	305-309	here	_	_	_	_	_	_	_
5-5	310-313	for	_	_	_	_	_	_	_
5-6	314-322	followup	_	_	_	_	cf2[24]	_	_
5-7	323-328	visit	_	_	_	_	cf2[24]	_	_
5-8	329-332	and	_	_	_	_	_	_	_
5-9	333-345	chemotherapy	_	_	_	_	cf3[25]	_	_
5-10	346-347	.	_	_	_	_	_	_	_

#Text=DIAGNOSES :
6-1	348-357	DIAGNOSES	_	_	_	_	cf1[26]	_	_
6-2	358-359	:	_	_	_	_	_	_	_

#Text=1. Posttransplant lymphoproliferative disorder .
7-1	360-362	1.	_	_	_	_	_	_	_
7-2	363-377	Posttransplant	abstract[29]	giv:inact[29]	sssss[29]	Post%2Dtransplant_lymphoproliferative_disorder[29]	cf1[29]	coref	13-11[46_29]
7-3	378-397	lymphoproliferative	abstract[29]	giv:inact[29]	sssss[29]	Post%2Dtransplant_lymphoproliferative_disorder[29]	cf1[29]	_	_
7-4	398-406	disorder	abstract[29]	giv:inact[29]	sssss[29]	Post%2Dtransplant_lymphoproliferative_disorder[29]	cf1[29]	_	_
7-5	407-408	.	_	_	_	_	_	_	_

#Text=2. Chronic renal insufficiency .
8-1	409-411	2.	_	_	_	_	_	_	_
8-2	412-419	Chronic	_	_	_	_	cf1[30]	_	_
8-3	420-425	renal	_	_	_	_	cf1[30]	_	_
8-4	426-439	insufficiency	_	_	_	_	cf1[30]	_	_
8-5	440-441	.	_	_	_	_	_	_	_

#Text=3. Squamous cell carcinoma of the skin .
9-1	442-444	3.	_	_	_	_	cf4[31]	_	_
9-2	445-453	Squamous	_	_	_	_	cf4[31]|cf2[32]|cf3[33]	_	_
9-3	454-458	cell	_	_	_	_	cf4[31]|cf2[32]|cf3[33]	_	_
9-4	459-468	carcinoma	_	_	_	_	cf4[31]|cf2[32]	_	_
9-5	469-471	of	_	_	_	_	cf4[31]|cf2[32]	_	_
9-6	472-475	the	object[34]	giv:inact[34]	snnnn[34]	_	cf4[31]|cf2[32]|cf1[34]	_	_
9-7	476-480	skin	object[34]	giv:inact[34]	snnnn[34]	_	cf4[31]|cf2[32]|cf1[34]	_	_
9-8	481-482	.	_	_	_	_	_	_	_

#Text=4. Anemia secondary to chronic renal insufficiency and chemotherapy .
10-1	483-485	4.	_	_	_	_	_	_	_
10-2	486-492	Anemia	_	_	_	_	cf1[35]	_	_
10-3	493-502	secondary	_	_	_	_	cf1[35]	_	_
10-4	503-505	to	_	_	_	_	cf1[35]	_	_
10-5	506-513	chronic	_	_	_	_	cf1[35]|cf2[36]	_	_
10-6	514-519	renal	_	_	_	_	cf1[35]|cf2[36]|cf4[37]	_	_
10-7	520-533	insufficiency	_	_	_	_	cf1[35]|cf2[36]	_	_
10-8	534-537	and	_	_	_	_	cf1[35]	_	_
10-9	538-550	chemotherapy	_	_	_	_	cf1[35]|cf3[38]	_	_
10-10	551-552	.	_	_	_	_	_	_	_

#Text=5. Hypertension .
11-1	553-555	5.	_	_	_	_	_	_	_
11-2	556-568	Hypertension	_	_	_	_	cf1[39]	_	_
11-3	569-570	.	_	_	_	_	_	_	_

#Text=HISTORY OF PRESENT ILLNESS :
12-1	571-578	HISTORY	_	_	_	_	cf1[43]	_	_
12-2	579-581	OF	_	_	_	_	cf1[43]	_	_
12-3	582-589	PRESENT	_	_	_	_	cf1[43]|cf2[44]	_	_
12-4	590-597	ILLNESS	_	_	_	_	cf1[43]|cf2[44]	_	_
12-5	598-599	:	_	_	_	_	_	_	_

#Text=A 51 - year - old white male diagnosed with PTLD in latter half of 2007 .
13-1	600-601	A	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	ana	14-1[50_45]
13-2	602-604	51	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	_	_
13-3	605-606	-	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	_	_
13-4	607-611	year	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	_	_
13-5	612-613	-	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	_	_
13-6	614-617	old	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	_	_
13-7	618-623	white	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	_	_
13-8	624-628	male	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	_	_
13-9	629-638	diagnosed	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	_	_
13-10	639-643	with	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	_	_
13-11	644-648	PTLD	person[45]|abstract[46]	giv:inact[45]|giv:inact[46]	sssss[45]|sssss[46]	Post%2Dtransplant_lymphoproliferative_disorder[46]	cf2[45]|cf1[46]	_	_
13-12	649-651	in	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]	_	_
13-13	652-658	latter	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]|cf3[48]	_	_
13-14	659-663	half	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]|cf3[48]	_	_
13-15	664-666	of	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]|cf3[48]	_	_
13-16	667-671	2007	person[45]	giv:inact[45]	sssss[45]	_	cf2[45]|cf3[48]|cf4[49]	_	_
13-17	672-673	.	_	_	_	_	_	_	_

#Text=He presented with symptoms of increasing adenopathy , abdominal pain , weight loss , and anorexia .
14-1	674-676	He	person[50]	giv:act[50]	sssss[50]	_	cf1*[50]	ana	15-1[59_50]
14-2	677-686	presented	_	_	_	_	_	_	_
14-3	687-691	with	_	_	_	_	_	_	_
14-4	692-700	symptoms	_	_	_	_	cf2[53]	_	_
14-5	701-703	of	_	_	_	_	cf2[53]	_	_
14-6	704-714	increasing	_	_	_	_	cf2[53]|cf3[54]	_	_
14-7	715-725	adenopathy	_	_	_	_	cf2[53]|cf3[54]	_	_
14-8	726-727	,	_	_	_	_	_	_	_
14-9	728-737	abdominal	_	_	_	_	cf4[55]	_	_
14-10	738-742	pain	_	_	_	_	cf4[55]	_	_
14-11	743-744	,	_	_	_	_	_	_	_
14-12	745-751	weight	_	_	_	_	cf5[56]|cf7[57]	_	_
14-13	752-756	loss	_	_	_	_	cf5[56]	_	_
14-14	757-758	,	_	_	_	_	_	_	_
14-15	759-762	and	_	_	_	_	_	_	_
14-16	763-771	anorexia	_	_	_	_	cf6[58]	_	_
14-17	772-773	.	_	_	_	_	_	_	_

#Text=He did not seek medical attention immediately .
15-1	774-776	He	person[59]	giv:act[59]	sssss[59]	_	cf1*[59]	ana	16-1[64_59]
15-2	777-780	did	_	_	_	_	_	_	_
15-3	781-784	not	_	_	_	_	_	_	_
15-4	785-789	seek	_	_	_	_	_	_	_
15-5	790-797	medical	_	_	_	_	cf2[63]	_	_
15-6	798-807	attention	_	_	_	_	cf2[63]	_	_
15-7	808-819	immediately	_	_	_	_	_	_	_
15-8	820-821	.	_	_	_	_	_	_	_

#Text=He was finally hospitalized by the renal transplant service and underwent a lymph node biopsy in the groin , which showed diagnosis of large cell lymphoma .
16-1	822-824	He	person[64]	giv:act[64]	sssss[64]	_	cf1*[64]	ana	17-1[75_64]
16-2	825-828	was	_	_	_	_	_	_	_
16-3	829-836	finally	_	_	_	_	_	_	_
16-4	837-849	hospitalized	_	_	_	_	_	_	_
16-5	850-852	by	_	_	_	_	_	_	_
16-6	853-856	the	_	_	_	_	_	_	_
16-7	857-862	renal	_	_	_	_	cf6[66]|cf8[67]|cf2[68]	_	_
16-8	863-873	transplant	_	_	_	_	cf6[66]|cf8[67]	_	_
16-9	874-881	service	_	_	_	_	cf6[66]	_	_
16-10	882-885	and	_	_	_	_	_	_	_
16-11	886-895	underwent	_	_	_	_	_	_	_
16-12	896-897	a	_	_	_	_	cf3[70]	_	_
16-13	898-903	lymph	_	_	_	_	cf3[70]|cf9[71]	_	_
16-14	904-908	node	_	_	_	_	cf3[70]|cf9[71]	_	_
16-15	909-915	biopsy	_	_	_	_	cf3[70]	_	_
16-16	916-918	in	_	_	_	_	cf3[70]	_	_
16-17	919-922	the	_	_	_	_	cf3[70]|cf5[72]	_	_
16-18	923-928	groin	_	_	_	_	cf3[70]|cf5[72]	_	_
16-19	929-930	,	_	_	_	_	cf3[70]	_	_
16-20	931-936	which	_	_	_	_	cf3[70]	_	_
16-21	937-943	showed	_	_	_	_	cf3[70]	_	_
16-22	944-953	diagnosis	_	_	_	_	cf3[70]|cf4[73]	_	_
16-23	954-956	of	_	_	_	_	cf3[70]|cf4[73]	_	_
16-24	957-962	large	_	_	_	_	cf3[70]|cf4[73]|cf7[74]	_	_
16-25	963-967	cell	_	_	_	_	cf3[70]|cf4[73]|cf7[74]	_	_
16-26	968-976	lymphoma	_	_	_	_	cf3[70]|cf4[73]|cf7[74]	_	_
16-27	977-978	.	_	_	_	_	_	_	_

#Text=He was discussed at the hematopathology conference .
17-1	979-981	He	person[75]	giv:act[75]	sssss[75]	_	cf1*[75]	ana	20-1[98_75]
17-2	982-985	was	_	_	_	_	_	_	_
17-3	986-995	discussed	_	_	_	_	_	_	_
17-4	996-998	at	_	_	_	_	_	_	_
17-5	999-1002	the	_	_	_	_	cf2[77]	_	_
17-6	1003-1018	hematopathology	_	_	_	_	cf2[77]|cf3[78]	_	_
17-7	1019-1029	conference	_	_	_	_	cf2[77]	_	_
17-8	1030-1031	.	_	_	_	_	_	_	_

#Text=Chemotherapy with rituximab plus cyclophosphamide , daunorubicin , vincristine , and prednisone was started .
18-1	1032-1044	Chemotherapy	_	_	_	_	cf1[80]	_	_
18-2	1045-1049	with	_	_	_	_	cf1[80]	_	_
18-3	1050-1059	rituximab	_	_	_	_	cf1[80]|cf2[81]	_	_
18-4	1060-1064	plus	_	_	_	_	cf1[80]	_	_
18-5	1065-1081	cyclophosphamide	_	_	_	_	cf1[80]|cf3[82]	_	_
18-6	1082-1083	,	_	_	_	_	cf1[80]	_	_
18-7	1084-1096	daunorubicin	_	_	_	_	cf1[80]|cf4[83]	_	_
18-8	1097-1098	,	_	_	_	_	cf1[80]	_	_
18-9	1099-1110	vincristine	_	_	_	_	cf1[80]|cf5[84]	_	_
18-10	1111-1112	,	_	_	_	_	cf1[80]	_	_
18-11	1113-1116	and	_	_	_	_	cf1[80]	_	_
18-12	1117-1127	prednisone	_	_	_	_	cf1[80]|cf6[85]	_	_
18-13	1128-1131	was	_	_	_	_	_	_	_
18-14	1132-1139	started	_	_	_	_	_	_	_
18-15	1140-1141	.	_	_	_	_	_	_	_

#Text=First cycle of chemotherapy was complicated by sepsis despite growth factor support .
19-1	1142-1147	First	_	_	_	_	cf2[91]	_	_
19-2	1148-1153	cycle	_	_	_	_	cf2[91]	_	_
19-3	1154-1156	of	_	_	_	_	cf2[91]	_	_
19-4	1157-1169	chemotherapy	_	_	_	_	cf2[91]|cf1*[92]	_	_
19-5	1170-1173	was	_	_	_	_	_	_	_
19-6	1174-1185	complicated	_	_	_	_	_	_	_
19-7	1186-1188	by	_	_	_	_	_	_	_
19-8	1189-1195	sepsis	_	_	_	_	cf3[93]	_	_
19-9	1196-1203	despite	_	_	_	_	_	_	_
19-10	1204-1210	growth	_	_	_	_	cf4[96]|cf5[97]	_	_
19-11	1211-1217	factor	_	_	_	_	cf4[96]|cf5[97]	_	_
19-12	1218-1225	support	_	_	_	_	cf4[96]	_	_
19-13	1226-1227	.	_	_	_	_	_	_	_

#Text=He also appeared to have become disoriented either secondary to sepsis or steroid therapy .
20-1	1228-1230	He	person[98]	giv:inact[98]	sssss[98]	_	cf2[98]	coref	21-1[105_98]
20-2	1231-1235	also	_	_	_	_	_	_	_
20-3	1236-1244	appeared	_	_	_	_	_	_	_
20-4	1245-1247	to	_	_	_	_	_	_	_
20-5	1248-1252	have	_	_	_	_	_	_	_
20-6	1253-1259	become	_	_	_	_	_	_	_
20-7	1260-1271	disoriented	_	_	_	_	_	_	_
20-8	1272-1278	either	_	_	_	_	_	_	_
20-9	1279-1288	secondary	_	_	_	_	_	_	_
20-10	1289-1291	to	_	_	_	_	_	_	_
20-11	1292-1298	sepsis	_	_	_	_	cf1*[99]	_	_
20-12	1299-1301	or	_	_	_	_	_	_	_
20-13	1302-1309	steroid	_	_	_	_	cf3[102]|cf4[103]	_	_
20-14	1310-1317	therapy	_	_	_	_	cf3[102]	_	_
20-15	1318-1319	.	_	_	_	_	_	_	_

#Text=The patient has received 5 cycles of chemotherapy to date .
21-1	1320-1323	The	person[105]	giv:act[105]	sssss[105]	_	cf1*[105]	ana	22-1[108_105]
21-2	1324-1331	patient	person[105]	giv:act[105]	sssss[105]	_	cf1*[105]	_	_
21-3	1332-1335	has	_	_	_	_	_	_	_
21-4	1336-1344	received	_	_	_	_	_	_	_
21-5	1345-1346	5	_	_	_	_	cf3[106]	_	_
21-6	1347-1353	cycles	_	_	_	_	cf3[106]	_	_
21-7	1354-1356	of	_	_	_	_	cf3[106]	_	_
21-8	1357-1369	chemotherapy	_	_	_	_	cf3[106]|cf2[107]	_	_
21-9	1370-1372	to	_	_	_	_	_	_	_
21-10	1373-1377	date	_	_	_	_	_	_	_
21-11	1378-1379	.	_	_	_	_	_	_	_

#Text=He did not keep his appointment for a PET scan after 3 cycles because he was not feeling well .
22-1	1380-1382	He	person[108]	giv:act[108]	sssss[108]	_	cf1*[108]	ana	22-5[112_108]
22-2	1383-1386	did	_	_	_	_	_	_	_
22-3	1387-1390	not	_	_	_	_	_	_	_
22-4	1391-1395	keep	_	_	_	_	_	_	_
22-5	1396-1399	his	person[112]	giv:act[112]	sssss[112]	_	cf2[111]|cf1*[112]	ana	22-15[118_112]
22-6	1400-1411	appointment	_	_	_	_	cf2[111]	_	_
22-7	1412-1415	for	_	_	_	_	cf2[111]	_	_
22-8	1416-1417	a	_	_	_	_	cf2[111]|cf3[114]	_	_
22-9	1418-1421	PET	_	_	_	_	cf2[111]|cf3[114]|cf5[115]	_	_
22-10	1422-1426	scan	_	_	_	_	cf2[111]|cf3[114]	_	_
22-11	1427-1432	after	_	_	_	_	cf2[111]	_	_
22-12	1433-1434	3	_	_	_	_	cf2[111]|cf4[117]	_	_
22-13	1435-1441	cycles	_	_	_	_	cf2[111]|cf4[117]	_	_
22-14	1442-1449	because	_	_	_	_	_	_	_
22-15	1450-1452	he	person[118]	giv:act[118]	sssss[118]	_	cf1*[118]	ana	23-1[121_118]
22-16	1453-1456	was	_	_	_	_	_	_	_
22-17	1457-1460	not	_	_	_	_	_	_	_
22-18	1461-1468	feeling	_	_	_	_	_	_	_
22-19	1469-1473	well	_	_	_	_	_	_	_
22-20	1474-1475	.	_	_	_	_	_	_	_

#Text=His therapy has been interrupted for infection related to squamous cell cancer , skin surgery as well as complaints of chest infection .
23-1	1476-1479	His	person[121]	giv:act[121]	sssss[121]	_	cf5[120]|cf1*[121]	coref	24-1[132_121]
23-2	1480-1487	therapy	_	_	_	_	cf5[120]	_	_
23-3	1488-1491	has	_	_	_	_	_	_	_
23-4	1492-1496	been	_	_	_	_	_	_	_
23-5	1497-1508	interrupted	_	_	_	_	_	_	_
23-6	1509-1512	for	_	_	_	_	_	_	_
23-7	1513-1522	infection	_	_	_	_	cf6[123]	_	_
23-8	1523-1530	related	_	_	_	_	cf6[123]	_	_
23-9	1531-1533	to	_	_	_	_	cf6[123]	_	_
23-10	1534-1542	squamous	_	_	_	_	cf6[123]|cf2[124]|cf3[125]	_	_
23-11	1543-1547	cell	_	_	_	_	cf6[123]|cf2[124]|cf3[125]	_	_
23-12	1548-1554	cancer	_	_	_	_	cf6[123]|cf2[124]	_	_
23-13	1555-1556	,	_	_	_	_	_	_	_
23-14	1557-1561	skin	_	_	_	_	cf7[126]|cf4[127]	_	_
23-15	1562-1569	surgery	_	_	_	_	cf7[126]	_	_
23-16	1570-1572	as	_	_	_	_	_	_	_
23-17	1573-1577	well	_	_	_	_	_	_	_
23-18	1578-1580	as	_	_	_	_	_	_	_
23-19	1581-1591	complaints	_	_	_	_	cf8[129]	_	_
23-20	1592-1594	of	_	_	_	_	cf8[129]	_	_
23-21	1595-1600	chest	_	_	_	_	cf8[129]|cf9[130]	_	_
23-22	1601-1610	infection	_	_	_	_	cf8[129]	_	_
23-23	1611-1612	.	_	_	_	_	_	_	_

#Text=The patient is here for the sixth and final cycle of chemotherapy .
24-1	1613-1616	The	person[132]	giv:act[132]	sssss[132]	_	cf1*[132]	ana	25-1[137_132]
24-2	1617-1624	patient	person[132]	giv:act[132]	sssss[132]	_	cf1*[132]	_	_
24-3	1625-1627	is	_	_	_	_	_	_	_
24-4	1628-1632	here	_	_	_	_	cf4[133]	_	_
24-5	1633-1636	for	_	_	_	_	_	_	_
24-6	1637-1640	the	_	_	_	_	cf3[135]	_	_
24-7	1641-1646	sixth	_	_	_	_	cf3[135]	_	_
24-8	1647-1650	and	_	_	_	_	cf3[135]	_	_
24-9	1651-1656	final	_	_	_	_	cf3[135]	_	_
24-10	1657-1662	cycle	_	_	_	_	cf3[135]	_	_
24-11	1663-1665	of	_	_	_	_	cf3[135]	_	_
24-12	1666-1678	chemotherapy	_	_	_	_	cf3[135]|cf2[136]	_	_
24-13	1679-1680	.	_	_	_	_	_	_	_

#Text=He states he feels well .
25-1	1681-1683	He	person[137]	giv:act[137]	sssss[137]	_	cf1*[137]	ana	25-3[138_137]
25-2	1684-1690	states	_	_	_	_	_	_	_
25-3	1691-1693	he	person[138]	giv:act[138]	sssss[138]	_	cf1*[138]	ana	26-1[139_138]
25-4	1694-1699	feels	_	_	_	_	_	_	_
25-5	1700-1704	well	_	_	_	_	_	_	_
25-6	1705-1706	.	_	_	_	_	_	_	_

#Text=He denies any nausea , vomiting , cough , shortness of breath , chest pain or fatigue .
26-1	1707-1709	He	person[139]	giv:act[139]	sssss[139]	_	cf1*[139]	ana	27-1[157_139]
26-2	1710-1716	denies	_	_	_	_	_	_	_
26-3	1717-1720	any	_	_	_	_	cf3[144]	_	_
26-4	1721-1727	nausea	_	_	_	_	cf3[144]|cf4[145]	_	_
26-5	1728-1729	,	_	_	_	_	_	_	_
26-6	1730-1738	vomiting	_	_	_	_	cf5[146]	_	_
26-7	1739-1740	,	_	_	_	_	_	_	_
26-8	1741-1746	cough	_	_	_	_	cf6[147]	_	_
26-9	1747-1748	,	_	_	_	_	_	_	_
26-10	1749-1758	shortness	_	_	_	_	cf7[151]	_	_
26-11	1759-1761	of	_	_	_	_	cf7[151]	_	_
26-12	1762-1768	breath	_	_	_	_	cf7[151]|cf8[152]	_	_
26-13	1769-1770	,	_	_	_	_	_	_	_
26-14	1771-1776	chest	_	_	_	_	cf9[154]|cf2[155]	_	_
26-15	1777-1781	pain	_	_	_	_	cf9[154]	_	_
26-16	1782-1784	or	_	_	_	_	_	_	_
26-17	1785-1792	fatigue	_	_	_	_	cf10[156]	_	_
26-18	1793-1794	.	_	_	_	_	_	_	_

#Text=He denies any tingling or numbness in his fingers .
27-1	1795-1797	He	person[157]	giv:act[157]	sssss[157]	_	cf1*[157]	ana	27-8[163_157]
27-2	1798-1804	denies	_	_	_	_	_	_	_
27-3	1805-1808	any	_	_	_	_	cf2[161]	_	_
27-4	1809-1817	tingling	_	_	_	_	cf2[161]	_	_
27-5	1818-1820	or	_	_	_	_	cf2[161]	_	_
27-6	1821-1829	numbness	_	_	_	_	cf2[161]	_	_
27-7	1830-1832	in	_	_	_	_	cf2[161]	_	_
27-8	1833-1836	his	person[163]	giv:act[163]	sssss[163]	_	cf2[161]|cf3[162]|cf1*[163]	ana	32-1[174_163]
27-9	1837-1844	fingers	_	_	_	_	cf2[161]|cf3[162]	_	_
27-10	1845-1846	.	_	_	_	_	_	_	_

#Text=Review of systems is otherwise entirely negative .
28-1	1847-1853	Review	_	_	_	_	cf1[165]	_	_
28-2	1854-1856	of	_	_	_	_	cf1[165]	_	_
28-3	1857-1864	systems	_	_	_	_	cf1[165]|cf2[166]	_	_
28-4	1865-1867	is	_	_	_	_	_	_	_
28-5	1868-1877	otherwise	_	_	_	_	_	_	_
28-6	1878-1886	entirely	_	_	_	_	_	_	_
28-7	1887-1895	negative	_	_	_	_	_	_	_
28-8	1896-1897	.	_	_	_	_	_	_	_

#Text=Performance status on the ECOG scale is 1
29-1	1898-1909	Performance	_	_	_	_	cf1[168]	_	_
29-2	1910-1916	status	_	_	_	_	cf1[168]	_	_
29-3	1917-1919	on	_	_	_	_	cf1[168]	_	_
29-4	1920-1923	the	_	_	_	_	cf1[168]|cf2[169]	_	_
29-5	1924-1928	ECOG	_	_	_	_	cf1[168]|cf2[169]	_	_
29-6	1929-1934	scale	_	_	_	_	cf1[168]|cf2[169]	_	_
29-7	1935-1937	is	_	_	_	_	_	_	_
29-8	1938-1939	1	_	_	_	_	cf1[170]	_	_

#Text=PHYSICAL EXAMINATION :
30-1	1940-1948	PHYSICAL	_	_	_	_	cf1[172]	_	_
30-2	1949-1960	EXAMINATION	_	_	_	_	cf1[172]	_	_
30-3	1961-1962	:	_	_	_	_	_	_	_

#Text=VITAL SIGNS :
31-1	1963-1968	VITAL	_	_	_	_	cf1[173]	_	_
31-2	1969-1974	SIGNS	_	_	_	_	cf1[173]	_	_
31-3	1975-1976	:	_	_	_	_	_	_	_

#Text=He is afebrile .
32-1	1977-1979	He	person[174]	giv:inact[174]	sssss[174]	_	cf1[174]	ana	33-19[188_174]
32-2	1980-1982	is	_	_	_	_	_	_	_
32-3	1983-1991	afebrile	_	_	_	_	_	_	_
32-4	1992-1993	.	_	_	_	_	_	_	_

#Text=Blood pressure 161 / 80 , pulse 65 , weight 71.5 kg , which is essentially unchanged from his prior visit .
33-1	1994-1999	Blood	_	_	_	_	cf3[176]|cf6[177]	_	_
33-2	2000-2008	pressure	_	_	_	_	cf3[176]	_	_
33-3	2009-2012	161	_	_	_	_	cf3[179]	_	_
33-4	2013-2014	/	_	_	_	_	cf3[179]	_	_
33-5	2015-2017	80	_	_	_	_	cf3[179]	_	_
33-6	2018-2019	,	_	_	_	_	_	_	_
33-7	2020-2025	pulse	_	_	_	_	cf4[180]	_	_
33-8	2026-2028	65	_	_	_	_	cf4[181]	_	_
33-9	2029-2030	,	_	_	_	_	_	_	_
33-10	2031-2037	weight	_	_	_	_	cf2[182]	_	_
33-11	2038-2042	71.5	_	_	_	_	cf2[186]	_	_
33-12	2043-2045	kg	_	_	_	_	cf2[186]	_	_
33-13	2046-2047	,	_	_	_	_	_	_	_
33-14	2048-2053	which	_	_	_	_	_	_	_
33-15	2054-2056	is	_	_	_	_	_	_	_
33-16	2057-2068	essentially	_	_	_	_	_	_	_
33-17	2069-2078	unchanged	_	_	_	_	_	_	_
33-18	2079-2083	from	_	_	_	_	_	_	_
33-19	2084-2087	his	person[188]	giv:act[188]	sssss[188]	_	cf5[187]|cf1*[188]	coref	46-1[260_188]
33-20	2088-2093	prior	_	_	_	_	cf5[187]	_	_
33-21	2094-2099	visit	_	_	_	_	cf5[187]	_	_
33-22	2100-2101	.	_	_	_	_	_	_	_

#Text=There is mild pallor noted .
34-1	2102-2107	There	_	_	_	_	_	_	_
34-2	2108-2110	is	_	_	_	_	_	_	_
34-3	2111-2115	mild	_	_	_	_	cf1[190]	_	_
34-4	2116-2122	pallor	_	_	_	_	cf1[190]	_	_
34-5	2123-2128	noted	_	_	_	_	_	_	_
34-6	2129-2130	.	_	_	_	_	_	_	_

#Text=There is no icterus , adenopathy or petechiae noted .
35-1	2131-2136	There	_	_	_	_	_	_	_
35-2	2137-2139	is	_	_	_	_	_	_	_
35-3	2140-2142	no	_	_	_	_	_	_	_
35-4	2143-2150	icterus	_	_	_	_	cf2[191]	_	_
35-5	2151-2152	,	_	_	_	_	_	_	_
35-6	2153-2163	adenopathy	_	_	_	_	cf1[192]	_	_
35-7	2164-2166	or	_	_	_	_	_	_	_
35-8	2167-2176	petechiae	_	_	_	_	cf3[193]	_	_
35-9	2177-2182	noted	_	_	_	_	_	_	_
35-10	2183-2184	.	_	_	_	_	_	_	_

#Text=CHEST : Clear to auscultation .
36-1	2185-2190	CHEST	_	_	_	_	cf1[194]	_	_
36-2	2191-2192	:	_	_	_	_	_	_	_
36-3	2193-2198	Clear	_	_	_	_	_	_	_
36-4	2199-2201	to	_	_	_	_	_	_	_
36-5	2202-2214	auscultation	_	_	_	_	cf2[195]	_	_
36-6	2215-2216	.	_	_	_	_	_	_	_

#Text=CARDIOVASCULAR : S1 and S2 normal with regular rate and rhythm .
37-1	2217-2231	CARDIOVASCULAR	_	_	_	_	cf4[196]	_	_
37-2	2232-2233	:	_	_	_	_	_	_	_
37-3	2234-2236	S1	_	_	_	_	cf1[197]	_	_
37-4	2237-2240	and	_	_	_	_	_	_	_
37-5	2241-2243	S2	_	_	_	_	cf2[198]	_	_
37-6	2244-2250	normal	_	_	_	_	_	_	_
37-7	2251-2255	with	_	_	_	_	_	_	_
37-8	2256-2263	regular	_	_	_	_	cf3[207]	_	_
37-9	2264-2268	rate	_	_	_	_	cf3[207]	_	_
37-10	2269-2272	and	_	_	_	_	cf3[207]	_	_
37-11	2273-2279	rhythm	_	_	_	_	cf3[207]	_	_
37-12	2280-2281	.	_	_	_	_	_	_	_

#Text=Systolic flow murmur is best heard in the pulmonary area .
38-1	2282-2290	Systolic	_	_	_	_	cf1[208]	_	_
38-2	2291-2295	flow	_	_	_	_	cf1[208]	_	_
38-3	2296-2302	murmur	_	_	_	_	cf1[208]	_	_
38-4	2303-2305	is	_	_	_	_	_	_	_
38-5	2306-2310	best	_	_	_	_	_	_	_
38-6	2311-2316	heard	_	_	_	_	_	_	_
38-7	2317-2319	in	_	_	_	_	_	_	_
38-8	2320-2323	the	_	_	_	_	cf2[209]	_	_
38-9	2324-2333	pulmonary	_	_	_	_	cf2[209]	_	_
38-10	2334-2338	area	_	_	_	_	cf2[209]	_	_
38-11	2339-2340	.	_	_	_	_	_	_	_

#Text=ABDOMEN : Soft and nontender with no organomegaly .
39-1	2341-2348	ABDOMEN	_	_	_	_	cf1[210]	_	_
39-2	2349-2350	:	_	_	_	_	_	_	_
39-3	2351-2355	Soft	_	_	_	_	_	_	_
39-4	2356-2359	and	_	_	_	_	_	_	_
39-5	2360-2369	nontender	_	_	_	_	_	_	_
39-6	2370-2374	with	_	_	_	_	_	_	_
39-7	2375-2377	no	_	_	_	_	_	_	_
39-8	2378-2390	organomegaly	_	_	_	_	cf2[211]	_	_
39-9	2391-2392	.	_	_	_	_	_	_	_

#Text=Renal transplant is noted in the right lower quadrant with a scar present .
40-1	2393-2398	Renal	_	_	_	_	cf1[214]|cf2[215]	_	_
40-2	2399-2409	transplant	_	_	_	_	cf1[214]	_	_
40-3	2410-2412	is	_	_	_	_	_	_	_
40-4	2413-2418	noted	_	_	_	_	_	_	_
40-5	2419-2421	in	_	_	_	_	_	_	_
40-6	2422-2425	the	_	_	_	_	cf4[217]	_	_
40-7	2426-2431	right	_	_	_	_	cf4[217]	_	_
40-8	2432-2437	lower	_	_	_	_	cf4[217]	_	_
40-9	2438-2446	quadrant	_	_	_	_	cf4[217]	_	_
40-10	2447-2451	with	_	_	_	_	_	_	_
40-11	2452-2453	a	_	_	_	_	cf3[218]	_	_
40-12	2454-2458	scar	_	_	_	_	cf3[218]	_	_
40-13	2459-2466	present	_	_	_	_	_	_	_
40-14	2467-2468	.	_	_	_	_	_	_	_

#Text=EXTREMITIES : Reveal no edema .
41-1	2469-2480	EXTREMITIES	_	_	_	_	cf2[219]	_	_
41-2	2481-2482	:	_	_	_	_	_	_	_
41-3	2483-2489	Reveal	_	_	_	_	_	_	_
41-4	2490-2492	no	_	_	_	_	cf1[221]	_	_
41-5	2493-2498	edema	_	_	_	_	cf1[221]	_	_
41-6	2499-2500	.	_	_	_	_	_	_	_

#Text=LABORATORY DATA :
42-1	2501-2511	LABORATORY	_	_	_	_	cf1[222]	_	_
42-2	2512-2516	DATA	_	_	_	_	cf1[222]	_	_
42-3	2517-2518	:	_	_	_	_	_	_	_

#Text=CBC from today shows white count of 9.6 with a normal differential , ANC of 7400 , hemoglobin 8.9 , hematocrit 26.5 with an MCV of 109 , and platelet count of 220,000 .
43-1	2519-2522	CBC	abstract[224]	new[224]	nnnnn[224]	Complete_blood_count[224]	cf8[223]|cf9[224]	coref	48-13[278_224]
43-2	2523-2527	from	_	_	_	_	cf8[223]	_	_
43-3	2528-2533	today	_	_	_	_	cf8[223]|cf7[225]	_	_
43-4	2534-2539	shows	_	_	_	_	_	_	_
43-5	2540-2545	white	_	_	_	_	cf1[228]	_	_
43-6	2546-2551	count	_	_	_	_	cf1[228]	_	_
43-7	2552-2554	of	_	_	_	_	cf1[228]	_	_
43-8	2555-2558	9.6	_	_	_	_	cf1[228]|cf1[229]	_	_
43-9	2559-2563	with	_	_	_	_	cf1[228]	_	_
43-10	2564-2565	a	_	_	_	_	cf1[228]|cf10[231]	_	_
43-11	2566-2572	normal	_	_	_	_	cf1[228]|cf10[231]	_	_
43-12	2573-2585	differential	_	_	_	_	cf1[228]|cf10[231]	_	_
43-13	2586-2587	,	_	_	_	_	_	_	_
43-14	2588-2591	ANC	_	_	_	_	cf2[232]	_	_
43-15	2592-2594	of	_	_	_	_	_	_	_
43-16	2595-2599	7400	_	_	_	_	cf2[233]	_	_
43-17	2600-2601	,	_	_	_	_	_	_	_
43-18	2602-2612	hemoglobin	_	_	_	_	cf3[234]	_	_
43-19	2613-2616	8.9	_	_	_	_	cf3[235]	_	_
43-20	2617-2618	,	_	_	_	_	_	_	_
43-21	2619-2629	hematocrit	_	_	_	_	cf4[236]	_	_
43-22	2630-2634	26.5	_	_	_	_	cf4[237]	_	_
43-23	2635-2639	with	_	_	_	_	_	_	_
43-24	2640-2642	an	_	_	_	_	cf5[244]	_	_
43-25	2643-2646	MCV	_	_	_	_	cf5[244]	_	_
43-26	2647-2649	of	_	_	_	_	cf5[244]	_	_
43-27	2650-2653	109	_	_	_	_	cf5[244]|cf5[245]	_	_
43-28	2654-2655	,	_	_	_	_	_	_	_
43-29	2656-2659	and	_	_	_	_	_	_	_
43-30	2660-2668	platelet	_	_	_	_	cf6[247]|cf11[248]	_	_
43-31	2669-2674	count	_	_	_	_	cf6[247]	_	_
43-32	2675-2677	of	_	_	_	_	cf6[247]	_	_
43-33	2678-2685	220,000	_	_	_	_	cf6[247]|cf6[249]	_	_
43-34	2686-2687	.	_	_	_	_	_	_	_

#Text=ASSESSMENT AND PLAN :
44-1	2688-2698	ASSESSMENT	_	_	_	_	cf1[250]	_	_
44-2	2699-2702	AND	_	_	_	_	_	_	_
44-3	2703-2707	PLAN	_	_	_	_	cf2[251]	_	_
44-4	2708-2709	:	_	_	_	_	_	_	_

#Text=1. Diffuse large B - cell lymphoma following transplantation .
45-1	2710-2712	1.	_	_	_	_	_	_	_
45-2	2713-2720	Diffuse	_	_	_	_	_	_	_
45-3	2721-2726	large	_	_	_	_	cf1[256]	_	_
45-4	2727-2728	B	_	_	_	_	cf1[256]|cf3[257]	_	_
45-5	2729-2730	-	_	_	_	_	cf1[256]|cf3[257]	_	_
45-6	2731-2735	cell	_	_	_	_	cf1[256]|cf3[257]	_	_
45-7	2736-2744	lymphoma	_	_	_	_	cf1[256]	_	_
45-8	2745-2754	following	_	_	_	_	_	_	_
45-9	2755-2770	transplantation	_	_	_	_	cf2[258]	_	_
45-10	2771-2772	.	_	_	_	_	_	_	_

#Text=The patient is to receive his sixth and final cycle of chemotherapy today .
46-1	2773-2776	The	person[260]	giv:inact[260]	sssss[260]	_	cf1[260]	ana	46-6[262_260]
46-2	2777-2784	patient	person[260]	giv:inact[260]	sssss[260]	_	cf1[260]	_	_
46-3	2785-2787	is	_	_	_	_	_	_	_
46-4	2788-2790	to	_	_	_	_	_	_	_
46-5	2791-2798	receive	_	_	_	_	_	_	_
46-6	2799-2802	his	person[262]	giv:act[262]	sssss[262]	_	cf4[261]|cf1[262]	ana	48-1[272_262]
46-7	2803-2808	sixth	_	_	_	_	cf4[261]	_	_
46-8	2809-2812	and	_	_	_	_	cf4[261]	_	_
46-9	2813-2818	final	_	_	_	_	cf4[261]	_	_
46-10	2819-2824	cycle	_	_	_	_	cf4[261]	_	_
46-11	2825-2827	of	_	_	_	_	cf4[261]	_	_
46-12	2828-2840	chemotherapy	_	_	_	_	cf4[261]|cf2[263]	_	_
46-13	2841-2846	today	_	_	_	_	cf3[264]	_	_
46-14	2847-2848	.	_	_	_	_	_	_	_

#Text=PET scan has been ordered to be done within 2 weeks .
47-1	2849-2852	PET	_	_	_	_	cf1[268]|cf2[269]	_	_
47-2	2853-2857	scan	_	_	_	_	cf1[268]	_	_
47-3	2858-2861	has	_	_	_	_	_	_	_
47-4	2862-2866	been	_	_	_	_	_	_	_
47-5	2867-2874	ordered	_	_	_	_	_	_	_
47-6	2875-2877	to	_	_	_	_	_	_	_
47-7	2878-2880	be	_	_	_	_	_	_	_
47-8	2881-2885	done	_	_	_	_	_	_	_
47-9	2886-2892	within	_	_	_	_	_	_	_
47-10	2893-2894	2	_	_	_	_	cf3[271]	_	_
47-11	2895-2900	weeks	_	_	_	_	cf3[271]	_	_
47-12	2901-2902	.	_	_	_	_	_	_	_

#Text=He will see me back for the visit in 3 weeks with CBC , CMP , and LDH .
48-1	2903-2905	He	person[272]	giv:inact[272]	sssss[272]	_	cf1[272]	ana	51-1[289_272]
48-2	2906-2910	will	_	_	_	_	_	_	_
48-3	2911-2914	see	_	_	_	_	_	_	_
48-4	2915-2917	me	_	_	_	_	cf3[273]	_	_
48-5	2918-2922	back	_	_	_	_	_	_	_
48-6	2923-2926	for	_	_	_	_	_	_	_
48-7	2927-2930	the	_	_	_	_	cf4[276]	_	_
48-8	2931-2936	visit	_	_	_	_	cf4[276]	_	_
48-9	2937-2939	in	_	_	_	_	cf4[276]	_	_
48-10	2940-2941	3	_	_	_	_	cf4[276]|cf7[277]	_	_
48-11	2942-2947	weeks	_	_	_	_	cf4[276]|cf7[277]	_	_
48-12	2948-2952	with	_	_	_	_	_	_	_
48-13	2953-2956	CBC	abstract[278]	giv:inact[278]	nnnnn[278]	Complete_blood_count[278]	cf2[278]	_	_
48-14	2957-2958	,	_	_	_	_	_	_	_
48-15	2959-2962	CMP	abstract[279]	new[279]	nnnnn[279]	Comprehensive_metabolic_panel[279]	cf5[279]	coref	54-1[318_279]
48-16	2963-2964	,	_	_	_	_	_	_	_
48-17	2965-2968	and	_	_	_	_	_	_	_
48-18	2969-2972	LDH	_	_	_	Lactate_dehydrogenase[280]	cf6[280]	_	_
48-19	2973-2974	.	_	_	_	_	_	_	_

#Text=2. Chronic renal insufficiency .
49-1	2975-2977	2.	_	_	_	_	_	_	_
49-2	2978-2985	Chronic	_	_	_	_	cf1[284]	_	_
49-3	2986-2991	renal	_	_	_	_	cf1[284]	_	_
49-4	2992-3005	insufficiency	_	_	_	_	cf1[284]	_	_
49-5	3006-3007	.	_	_	_	_	_	_	_

#Text=3. Anemia secondary to chronic renal failure and chemotherapy .
50-1	3008-3010	3.	_	_	_	_	_	_	_
50-2	3011-3017	Anemia	_	_	_	_	cf1[285]	_	_
50-3	3018-3027	secondary	_	_	_	_	cf1[285]	_	_
50-4	3028-3030	to	_	_	_	_	cf1[285]	_	_
50-5	3031-3038	chronic	_	_	_	_	cf1[285]|cf4[286]	_	_
50-6	3039-3044	renal	_	_	_	_	cf1[285]|cf4[286]|cf3[287]	_	_
50-7	3045-3052	failure	_	_	_	_	cf1[285]|cf4[286]	_	_
50-8	3053-3056	and	_	_	_	_	cf1[285]	_	_
50-9	3057-3069	chemotherapy	_	_	_	_	cf1[285]|cf2[288]	_	_
50-10	3070-3071	.	_	_	_	_	_	_	_

#Text=He is to continue on his regimen of growth factor support .
51-1	3072-3074	He	person[289]	giv:inact[289]	sssss[289]	_	cf1[289]	ana	51-6[294_289]
51-2	3075-3077	is	_	_	_	_	_	_	_
51-3	3078-3080	to	_	_	_	_	_	_	_
51-4	3081-3089	continue	_	_	_	_	_	_	_
51-5	3090-3092	on	_	_	_	_	_	_	_
51-6	3093-3096	his	person[294]	giv:act[294]	sssss[294]	_	cf4[293]|cf1[294]	ana	53-6[305_294]
51-7	3097-3104	regimen	_	_	_	_	cf4[293]	_	_
51-8	3105-3107	of	_	_	_	_	cf4[293]	_	_
51-9	3108-3114	growth	_	_	_	_	cf4[293]|cf2[296]|cf3[297]	_	_
51-10	3115-3121	factor	_	_	_	_	cf4[293]|cf2[296]|cf3[297]	_	_
51-11	3122-3129	support	_	_	_	_	cf4[293]|cf2[296]	_	_
51-12	3130-3131	.	_	_	_	_	_	_	_

#Text=4. Hypertension .
52-1	3132-3134	4.	_	_	_	_	_	_	_
52-2	3135-3147	Hypertension	abstract[298]	giv:inact[298]	sssns[298]	_	cf1[298]	ana	53-1[299_298]
52-3	3148-3149	.	_	_	_	_	_	_	_

#Text=This is elevated today because he held his meds because he is getting rituximab other than that this is well controlled .
53-1	3150-3154	This	abstract[299]	giv:act[299]	sssns[299]	_	cf2*[299]	ana	53-18[312_299]
53-2	3155-3157	is	_	_	_	_	_	_	_
53-3	3158-3166	elevated	_	_	_	_	_	_	_
53-4	3167-3172	today	_	_	_	_	cf4[300]	_	_
53-5	3173-3180	because	_	_	_	_	_	_	_
53-6	3181-3183	he	person[305]	giv:inact[305]	sssss[305]	_	cf3[304]|cf1[305]	ana	53-8[308_305]
53-7	3184-3188	held	event[381]	new[381]	_	_	cf3[304]	disc	53-17[311_381]
53-8	3189-3192	his	person[308]	giv:act[308]	sssss[308]	_	cf3[304]|cf5[307]|cf1[308]	ana	53-11[309_308]
53-9	3193-3197	meds	_	_	_	_	cf3[304]|cf5[307]	_	_
53-10	3198-3205	because	_	_	_	_	cf3[304]	_	_
53-11	3206-3208	he	person[309]	giv:act[309]	sssss[309]	_	cf3[304]|cf1[309]	ana	54-1[319_309]
53-12	3209-3211	is	_	_	_	_	cf3[304]	_	_
53-13	3212-3219	getting	_	_	_	_	cf3[304]	_	_
53-14	3220-3229	rituximab	_	_	_	_	cf3[304]|cf6[310]	_	_
53-15	3230-3235	other	_	_	_	_	_	_	_
53-16	3236-3240	than	_	_	_	_	_	_	_
53-17	3241-3245	that	event[311]	giv:act[311]	nnnnn[311]	_	cf3[311]	_	_
53-18	3246-3250	this	abstract[312]	giv:act[312]	sssns[312]	_	cf2*[312]	_	_
53-19	3251-3253	is	_	_	_	_	_	_	_
53-20	3254-3258	well	_	_	_	_	_	_	_
53-21	3259-3269	controlled	_	_	_	_	_	_	_
53-22	3270-3271	.	_	_	_	_	_	_	_

#Text=His CMP is pending from today .
54-1	3272-3275	His	abstract[318]|person[319]	giv:inact[318]|giv:act[319]	nnnnn[318]|sssss[319]	Comprehensive_metabolic_panel[318]	cf3[318]|cf1*[319]	ana	57-1[328_319]
54-2	3276-3279	CMP	abstract[318]	giv:inact[318]	nnnnn[318]	Comprehensive_metabolic_panel[318]	cf3[318]	_	_
54-3	3280-3282	is	_	_	_	_	_	_	_
54-4	3283-3290	pending	_	_	_	_	_	_	_
54-5	3291-3295	from	_	_	_	_	_	_	_
54-6	3296-3301	today	_	_	_	_	cf2[320]	_	_
54-7	3302-3303	.	_	_	_	_	_	_	_

#Text=5. Squamous cell carcinoma of the skin .
55-1	3304-3306	5.	_	_	_	_	_	_	_
55-2	3307-3315	Squamous	_	_	_	_	cf1[323]|cf1[324]|cf3[325]	_	_
55-3	3316-3320	cell	_	_	_	_	cf1[323]|cf1[324]|cf3[325]	_	_
55-4	3321-3330	carcinoma	_	_	_	_	cf1[323]|cf1[324]	_	_
55-5	3331-3333	of	_	_	_	_	cf1[323]	_	_
55-6	3334-3337	the	_	_	_	_	cf1[323]|cf2[326]	_	_
55-7	3338-3342	skin	_	_	_	_	cf1[323]|cf2[326]	_	_
55-8	3343-3344	.	_	_	_	_	_	_	_

#Text=The scalp is well healed .
56-1	3345-3348	The	_	_	_	_	cf1[327]	_	_
56-2	3349-3354	scalp	_	_	_	_	cf1[327]	_	_
56-3	3355-3357	is	_	_	_	_	_	_	_
56-4	3358-3362	well	_	_	_	_	_	_	_
56-5	3363-3369	healed	_	_	_	_	_	_	_
56-6	3370-3371	.	_	_	_	_	_	_	_

#Text=He still has an open wound on the right posterior aspect of his trunk .
57-1	3372-3374	He	person[328]	giv:inact[328]	sssss[328]	_	cf1[328]	ana	57-13[333_328]
57-2	3375-3380	still	_	_	_	_	_	_	_
57-3	3381-3384	has	_	_	_	_	_	_	_
57-4	3385-3387	an	object[330]	new[330]	nnnns[330]	_	cf2[330]	ana	58-1[334_330]
57-5	3388-3392	open	object[330]	new[330]	nnnns[330]	_	cf2[330]	_	_
57-6	3393-3398	wound	object[330]	new[330]	nnnns[330]	_	cf2[330]	_	_
57-7	3399-3401	on	object[330]	new[330]	nnnns[330]	_	cf2[330]	_	_
57-8	3402-3405	the	object[330]	new[330]	nnnns[330]	_	cf2[330]|cf3[331]	_	_
57-9	3406-3411	right	object[330]	new[330]	nnnns[330]	_	cf2[330]|cf3[331]	_	_
57-10	3412-3421	posterior	object[330]	new[330]	nnnns[330]	_	cf2[330]|cf3[331]	_	_
57-11	3422-3428	aspect	object[330]	new[330]	nnnns[330]	_	cf2[330]|cf3[331]	_	_
57-12	3429-3431	of	object[330]	new[330]	nnnns[330]	_	cf2[330]|cf3[331]	_	_
57-13	3432-3435	his	object[330]|person[333]	new[330]|giv:act[333]	nnnns[330]|sssss[333]	_	cf2[330]|cf3[331]|cf4[332]|cf1[333]	ana	60-7[349_333]
57-14	3436-3441	trunk	object[330]	new[330]	nnnns[330]	_	cf2[330]|cf3[331]|cf4[332]	_	_
57-15	3442-3443	.	_	_	_	_	_	_	_

#Text=This has no active drainage , but it is yet to heal .
58-1	3444-3448	This	object[334]	giv:act[334]	nnnns[334]	_	cf1*[334]	ana	58-8[338_334]
58-2	3449-3452	has	_	_	_	_	_	_	_
58-3	3453-3455	no	_	_	_	_	_	_	_
58-4	3456-3462	active	_	_	_	_	cf2[337]	_	_
58-5	3463-3471	drainage	_	_	_	_	cf2[337]	_	_
58-6	3472-3473	,	_	_	_	_	_	_	_
58-7	3474-3477	but	_	_	_	_	_	_	_
58-8	3478-3480	it	object[338]	giv:act[338]	nnnns[338]	_	cf1*[338]	ana	59-1[339_338]
58-9	3481-3483	is	_	_	_	_	_	_	_
58-10	3484-3487	yet	_	_	_	_	_	_	_
58-11	3488-3490	to	_	_	_	_	_	_	_
58-12	3491-3495	heal	_	_	_	_	_	_	_
58-13	3496-3497	.	_	_	_	_	_	_	_

#Text=This probably will heal by secondary intention once chemotherapy is finished .
59-1	3498-3502	This	object[339]	giv:act[339]	nnnns[339]	_	cf1*[339]	_	_
59-2	3503-3511	probably	_	_	_	_	_	_	_
59-3	3512-3516	will	_	_	_	_	_	_	_
59-4	3517-3521	heal	_	_	_	_	_	_	_
59-5	3522-3524	by	_	_	_	_	_	_	_
59-6	3525-3534	secondary	_	_	_	_	cf3[342]	_	_
59-7	3535-3544	intention	_	_	_	_	cf3[342]	_	_
59-8	3545-3549	once	_	_	_	_	_	_	_
59-9	3550-3562	chemotherapy	event[343]	giv:inact[343]	ssssn[343]	_	cf2[343]	coref	60-7[348_343]
59-10	3563-3565	is	_	_	_	_	_	_	_
59-11	3566-3574	finished	_	_	_	_	_	_	_
59-12	3575-3576	.	_	_	_	_	_	_	_

#Text=Prescription for prednisone as part of his chemotherapy has been given to him .
60-1	3577-3589	Prescription	_	_	_	_	cf3[345]	_	_
60-2	3590-3593	for	_	_	_	_	cf3[345]	_	_
60-3	3594-3604	prednisone	_	_	_	_	cf3[345]|cf4[346]	_	_
60-4	3605-3607	as	_	_	_	_	cf3[345]	_	_
60-5	3608-3612	part	_	_	_	_	cf3[345]	_	_
60-6	3613-3615	of	_	_	_	_	cf3[345]	_	_
60-7	3616-3619	his	event[348]|person[349]	giv:act[348]|giv:inact[349]	ssssn[348]|sssss[349]	_	cf3[345]|cf2*[348]|cf1[349]	ana	60-13[350_349]
60-8	3620-3632	chemotherapy	event[348]	giv:act[348]	ssssn[348]	_	cf3[345]|cf2*[348]	_	_
60-9	3633-3636	has	_	_	_	_	_	_	_
60-10	3637-3641	been	_	_	_	_	_	_	_
60-11	3642-3647	given	_	_	_	_	_	_	_
60-12	3648-3650	to	_	_	_	_	_	_	_
60-13	3651-3654	him	person[350]	giv:act[350]	sssss[350]	_	cf1[350]	_	_
60-14	3655-3656	.	_	_	_	_	_	_	_

